Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gluco-Chaser is a medical technology company based in Taiwan that specializes in the development of non-invasive continuous glucose monitoring (CGM) systems. The company's core technology utilizes a proprietary electrochemical sensor and a wearable patch design to measure glucose levels through the skin without the need for finger-pricking or invasive needles. Gluco-Chaser aims to improve the quality of life for individuals with diabetes by providing a painless, real-time monitoring solution that integrates with mobile applications for data tracking and management. The company is currently advancing its device through clinical validation and regulatory approval processes to bring its innovative solution to global markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gluco-Chaser.